1-4 of 4
Stefan Krause, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real Life Experience with ATRA-Arsenic Trioxide Based Regimen in Acute Promyelocytic Leukemia - Updated Results of the Prospective German Intergroup Napoleon Registry

Uwe Platzbecker, MD, Eva Lengfelder, MD, Kerstin Schäfer-Eckart, MD, Katharina S Götze, MD, Michael Heuser, MD, Felicitas Thol, MD, Helmut R. Salih, MD, Mathias Hänel, MD, Karsten Spiekermann, Sonja Martin, MD, Sigrid Machherndl-Spandl, MD, Volker Kunzmann, MD, Andreas Jakob, MD, Hans-Joachim Tischler, MD, Dirk Niemann, MD, Joerg Mezger, MD, Tilmann Bochtler, MD, Stefan Krause, MD, Maike de Wit, MD, Claudia D. Baldus, MD, Richard Greil, MD, Jochen Greiner, Mark Ringhoffer, MD, Markus Radsak, MD, Mohammed Amen Wattad, MD, Wolff Schmiegel, MD, Elisabeth Koller, MD, Frank Heits, MD, Albrecht Reichle, MD, Stephan Kremers, MD, Andreas Hochhaus, MD, Nadezda Basara, MD, Dominik Wolf, MD, Martin Goerner, MD, Markus Schaich, MD, Harald Biersack, MD, Heinz Kirchen, MD, Thomas Kubin, MD, Gregor Aschauer, MD, Tanja Hesse, MD, Hartmut Link, MD PhD, Heinz Duerk, MDPhD, Dorit Kuerschner, MD, Walter Fiedler, MD, Bernd Hertenstein, MD, Martin Puttrich, Michael Kramer, M.Sc., Michaela Sauer, Wolfgang Hiddemann, Ulrich Duehrsen, MD, Hubert Serve, Christian Thiede, MD, Arnold Ganser, MD, Tim H. Brummendorf, MD, Konstanze Dohner, MD, Martin Bornhäuser, MD, Richard F. Schlenk, MD, Christoph Rollig, MD MSC, Hartmut Döhner, MD, Gerhard Ehninger, Peter Paschka, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2618.
https://doi.org/10.1182/blood.V130.Suppl_1.2618.2618
Published: 2017
Journal Articles

Y-90 Ibritumomab Tiuxetan as Consolidation Following Three Cycles of Fludarabine-Cyclophosphamide-Rituximab Chemoimmunotherapy in Patients with Relapsed Follicular, Indolent or Mantle-Cell Lymphoma: A Prospective “Dose”-Finding Study.

Christoph von Schilling, MD, Kathleen Schwarz, MD, Georg Hess, MD., Ph.D., Andreas Viardot, MD, Michael Sandherr, MD, Stefan Krause, MD., Ph.D., Jan P. Simon, MD, Ph.D., Nadine Roethling, Christian Peschel, MD, Ph.D., Markus Schwaiger, MD, Ph.D., Klemens Scheidhauer, MD, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 3426.
https://doi.org/10.1182/blood.V110.11.3426.3426
Published: 2007
Journal Articles

Concept, Feasibility and Results of the Randomized Comparison of Imatinib Combination Therapies for Chronic Myeloid Leukemia: The German CML-Study IV.

Ute Berger, MD, Andreas Hochhaus, MD, Markus Pfirrmann, Claudia Schoch, MD, Andreas Reiter, MD, Gerhard Ehninger, MD, Thomas Fischer, MD, Alois Gratwohl, MD, Joerg Hasford, MD, Hermann Heimpel, MD, Dieter K. Hossfeld, MD, Hans-J. Kolb, MD, Stefan Krause, MD, Christoph Nerl, MD, Hans Pralle, MD, Andreas Tobler, MD, Ruediger Hehlmann, MD, The German CML-Study Group
Journal: Blood
Blood (2005) 106 (11): 1083.
https://doi.org/10.1182/blood.V106.11.1083.1083
Published: 2005
Journal Articles

Feasibility of Imatinib Combination Therapies in a Randomized Trial for Chronic Myeloid Leukemia: The German CML-Study IV - Pilot Phase.

Ute Berger, MD, Andreas Hochhaus, MD, Andreas Reiter, MD, Markus Pfirrmann, Claudia Schoch, MD, Gerhard Ehninger, MD, Thomas Fischer, MD, Alois Gratwohl, MD, Joerg Hasford, MD, Hermann Heimpel, MD, Dieter K. Hossfeld, MD, Hans-J. Kolb, MD, Stefan Krause, MD, Christoph Nerl, MD, Hans Pralle, MD, Andreas Tobler, MD, Rüdiger Hehlmann, MD, the German CML-Study Group
Journal: Blood
Blood (2004) 104 (11): 24.
https://doi.org/10.1182/blood.V104.11.24.24
Published: 2004